The binding of PD-1 on T cells to PD-L1 on tumour cells (which could mimic an APC) disrupts TCR signalling, thereby leading to the inhibition of T cell survival, proliferation and suppression of their effector function. This evidence concerns the gene CD274 and neoplasm.